These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21223289)

  • 1. Storage of whole blood for up to 24 hours at ambient temperature before component preparation: implementation in the Netherlands.
    Pietersz RN
    Transfusion; 2011 Jan; 51 Suppl 1():3S-6S. PubMed ID: 21223289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitating blood component preparation: the impact of overnight room temperature storage.
    McLaughlin LS; Moroff G; Benjamin RJ
    Transfusion; 2010 Feb; 50(2):278-80. PubMed ID: 20088837
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma and cryoprecipitate manufactured from whole blood held overnight at room temperature meet quality standards.
    Serrano K; Scammell K; Weiss S; Culibrk B; Levin E; Gyöngyössy-Issa M; Devine DV
    Transfusion; 2010 Feb; 50(2):344-53. PubMed ID: 19843287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the properties of components prepared and stored after holding of whole blood units for 8 and 24 hours at ambient temperature.
    Moroff G; AuBuchon JP; Pickard C; Whitley PH; Heaton WA; Holme S
    Transfusion; 2011 Jan; 51 Suppl 1():7S-14S. PubMed ID: 21223290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation factor content of plasma produced from whole blood stored for 24 hours at ambient temperature: results from an international multicenter BEST Collaborative study.
    Cardigan R; Van der Meer PF; Pergande C; Cookson P; Baumann-Baretti B; Cancelas JA; Devine D; Gulliksson H; Vassallo R; de Wildt-Eggen J
    Transfusion; 2011 Jan; 51 Suppl 1():50S-57S. PubMed ID: 21223296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The implementation of rapid cooling and overnight hold of whole blood at ambient temperature before processing into components in Israel.
    Shinar E; Etlin S; Frenkel O; Yahalom V
    Transfusion; 2011 Jan; 51 Suppl 1():58S-64S. PubMed ID: 21223297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the overnight hold of whole blood at room temperature, before component processing: platelets (PLTs) from PLT-rich plasma.
    van der Meer PF; Cancelas JA; Vassallo RR; Rugg N; Einarson M; Hess JR;
    Transfusion; 2011 Jan; 51 Suppl 1():45S-49S. PubMed ID: 21223295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red cell freezing and its impact on the supply chain.
    Hess JR
    Transfus Med; 2004 Feb; 14(1):1-8. PubMed ID: 15043586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A minipool process for solvent-detergent treatment of cryoprecipitate at blood centres using a disposable bag system.
    Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M
    Vox Sang; 2006 Jul; 91(1):56-62. PubMed ID: 16756602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Self-sufficiency with factor VIII in Norway. Use of freeze-dried cryoprecipitates instead of purified factor VIII concentrates].
    Solheim BG; Evensen SA; Stavem P; Glomstein A
    Tidsskr Nor Laegeforen; 1986 Jan; 106(1):16-8. PubMed ID: 3082031
    [No Abstract]   [Full Text] [Related]  

  • 11. [Techniques of preparation and indications of labile blood products].
    Clément S
    Transfus Clin Biol; 2011 Apr; 18(2):250-61. PubMed ID: 21474355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on solutions for red cell storage.
    Hess JR
    Vox Sang; 2006 Jul; 91(1):13-9. PubMed ID: 16756596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The overnight warm hold of whole blood before processing into blood components.
    Hess JR
    Transfusion; 2011 Jan; 51 Suppl 1():1S-2S. PubMed ID: 21223288
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemophilia: the blood bank's concern?].
    Smit Sibinga CT
    Ned Tijdschr Geneeskd; 1978 Sep; 122(37):1359-62. PubMed ID: 692762
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma fractionation issues.
    Farrugia A; Evers T; Falcou PF; Burnouf T; Amorim L; Thomas S
    Biologicals; 2009 Apr; 37(2):88-93. PubMed ID: 19289290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The need for recombinant factor VIII: historical background and rationale.
    Hilgartner MW
    Semin Hematol; 1991 Apr; 28(2 Suppl 1):6-9. PubMed ID: 1908132
    [No Abstract]   [Full Text] [Related]  

  • 17. Prestorage leukocyte reduction of cellular blood components.
    Dzik S
    Transfus Sci; 1994 Jun; 15(2):131-9. PubMed ID: 10147358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet concentrates from fresh or overnight-stored blood, an international study.
    Dijkstra-Tiekstra MJ; van der Meer PF; Cardigan R; Devine D; Prowse C; Sandgren P; de Wildt-Eggen J;
    Transfusion; 2011 Jan; 51 Suppl 1():38S-44S. PubMed ID: 21223294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twenty years of treatment with Beriate® P.
    Brackmann HH
    Thromb Res; 2014 Nov; 134 Suppl 1():S1-3. PubMed ID: 24360930
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of overnight hold of whole blood at room temperature before component processing: effect of red blood cell (RBC) additive solutions on in vitro RBC measures.
    van der Meer PF; Cancelas JA; Cardigan R; Devine DV; Gulliksson H; Sparrow RL; Vassallo RR; de Wildt-Eggen J; Baumann-Baretti B; Hess JR;
    Transfusion; 2011 Jan; 51 Suppl 1():15S-24S. PubMed ID: 21223291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.